Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0001193125-26-025012

Chief Accounting Officer sold 72,572 shares at an average $33.29 ($2,415,843)

  • Chief Accounting Officer acquired 72,572 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kooij Louise Frederika · Chief Accounting Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-23 Exercise or conversion : show line 1 in the form 10b5-1 +38,172 $10.90 $416,075 62,525 D
2026-01-23 Sale : show line 2 in the form 10b5-1 −25,405 $33.44 $849,543 37,120 D
2026-01-23 Sale : show line 3 in the form 10b5-1 −12,767 $34.37 $438,802 24,353 D
2026-01-26 Exercise or conversion : show line 4 in the form 10b5-1 +34,400 $10.90 $374,960 58,753 D
2026-01-26 Sale : show line 5 in the form 10b5-1 −34,091 $32.77 $1,117,162 24,662 D
2026-01-26 Sale : show line 6 in the form 10b5-1 −309 $33.45 $10,336 24,353 D
Open-market sales · 72,572 sh · avg $33.29 · $2,415,843

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-23 Exercise or conversion : show line 7 in the form 10b5-1 Option (right to buy) −38,172 179,962 D
2026-01-26 Exercise or conversion : show line 8 in the form 10b5-1 Option (right to buy) −34,400 145,562 D
Loading xslF345X05/ownership.xml…